Activated PBMCs from patients with MS in co-culture with autologous MSCs significantly increased the proportion of T cells expressing IL-17 (Th17, p = 0.0112, Figure 2A) and GM-CSF (Th-GM, p = 0.03, Figure 2B). The gene discussed is IL17A; the disease is myeloid sarcoma.